Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Share-based Compensation (2023 - 2026)

Adagio Medical Holdings has reported Share-based Compensation over the past 4 years, most recently at $389000.0 for Q1 2026.

  • Quarterly Share-based Compensation rose 78.44% to $389000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Mar 2026, up 198.91% year-over-year, with the annual reading at $1.5 million for FY2025, N/A changed from the prior year.
  • Share-based Compensation was $389000.0 for Q1 2026 at Adagio Medical Holdings, down from $890000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $890000.0 in Q4 2025 and troughed at $110000.0 in Q1 2024.
  • The 4-year median for Share-based Compensation is $177500.0 (2025), against an average of $275250.0.
  • Year-over-year, Share-based Compensation surged 110.81% in 2025 and then skyrocketed 78.44% in 2026.
  • A 4-year view of Share-based Compensation shows it stood at $113000.0 in 2023, then dropped by 1.77% to $111000.0 in 2024, then soared by 701.8% to $890000.0 in 2025, then plummeted by 56.29% to $389000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Share-based Compensation are $389000.0 (Q1 2026), $890000.0 (Q4 2025), and $137000.0 (Q3 2025).